Skip to content
10-Q

Quarterly Report

HUBEI MINKANG PHARMACEUTICAL LTD.

0001354488-13-002912

← back to feed
Filed
May 15, 2013 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2013 · May 14, 2013 52.19M sh
Stockholders Equity Q1 2013 · Mar 31, 2013 $10.72M
Stockholders Equity Q1 2013 · Dec 31, 2011 $7.53M
Current Liabilities Q1 2013 · Mar 31, 2013 $9.77M
Current Liabilities Q1 2013 · Dec 31, 2012 $9.54M
Total Liabilities Q1 2013 · Mar 31, 2013 $9.77M
Total Liabilities Q1 2013 · Dec 31, 2012 $9.54M
Current Assets Q1 2013 · Mar 31, 2013 $13.26M
Current Assets Q1 2013 · Dec 31, 2012 $13.2M
Total Assets Q1 2013 · Mar 31, 2013 $20.49M
Total Assets Q1 2013 · Dec 31, 2012 $20.49M
Net Income Q1 2013 · Dec 31, 2012 $961.12K
Net Income Q1 2013 · Mar 31, 2012 $33.42K
Operating Cash Flow Q1 2013 · Mar 31, 2012 −$74.63K
Sga Expense restated Q1 2013 · Mar 31, 2012 $655.35K
Rd Expense Q1 2013 · Mar 31, 2012 $9.33K
Operating Income Q1 2013 · Mar 31, 2012 $137.72K
Gross Profit Q1 2013 · Mar 31, 2012 $1.22M
Revenue Q1 2013 · Mar 31, 2012 $2.69M
Cash And Equivalents Q1 2013 · Dec 31, 2011 $3.1M